Our study also found that the amount of CD4+CD25+FoxP3+ regulatory T cells in tumor tissue of Hepal-1 hepatoma-bearing mice was significantly decreased in the NCTD+CLSO combination treated group. The gene discussed is CD4; the disease is hepatocellular carcinoma.